Treatment Access News
Health Canada has issued a NOC for Truvada as PrEP
march 1, 2016
Health Canada has issued a Notice of Compliance for once-daily oral Truvada® (emtricitabine 200mg/tenofovir disoproxil fumarate 300mg) in combination with safer sex practices to reduce the risk of sexually acquired HIV-1 infection in adults at high risk, a strategy known as Pre-Exposure Prophylaxis (PrEP).
This is a critical milestone in the evolution of HIV/AIDS healthcare!